Drawing for BRILL ENGINES

USPTO serial 79298897

BRILL ENGINES

Reviewed by CopyMark Law Group

Reg. 6874449Status 700Registered
Filing date
Status date
Registration date
Oct 18, 2022
Examiner
PEREZ, STEVEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BRILL ENGINES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical use and products thereof, namely, sanitary sterilizing preparations; dental preparations, namely, medicated dental rinses as well as medicated dentifrices; products for air deodorizing and purification, namely, air deodorizing and purifying preparations; preparations for pest control, namely, anti-insect spray; dietetic preparations adapted for medical purposes and supplements, namely, dietary and nutritional supplements; disinfectants and antiseptics; disinfecting and medicinal detergents and soaps; absorbent products for personal hygiene, namely eye pads, eye compresses and eye patches for medical use; collyrium; ophthalmological preparations; chemical preparations for sanitary use; hygienic and sanitary products for medical use, namely cleaning solutions for medical use and/or for use in ocular or intraocular surgery; drugs being pharmaceutical preparations for ocular or intraocular surgery and/or for the treatment of eye diseases and conditions, allergic rhinitis and asthma; agents for administering medicines namely, drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals, dissolvable films, coatings for tablets, powders, tablets and capsules that facilitate the delivery of pharmaceutical preparations and provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines being pharmaceutical preparations for the treatment of eye diseases and conditions, allergic rhinitis and/or asthma, and/or for ocular or intraocular surgeryACTIVE—
010Medical and veterinary apparatus and instruments, namely, nebulizers for medical purposes and magnifying glasses for medical examination purposes; beds and furniture especially made for medical purposes; equipment for moving patients, namely, a low friction pad for sliding patients to or from a stretcher and bed; pacifiers for babies and utensils for assistance in feeding, namely, baby feeding pacifiers; equipment for medical diagnosis, examination and monitoring, namely eye pressure monitors, X-ray diagnostic apparatus; surgical instruments and instruments for the treatment of wounds, namely, medical devices for closing wounds and medical devices for measuring wounds; respiratory masks and apparatus for artificial respiration; ophthalmic instruments, namely, surgical instruments for use in ophthalmic surgery; ophthalmological instruments, namely, stethoscopes, ophthalmoscopes, retinoscopes; diagnostic instruments for ophthalmology; therapeutic instruments for ophthalmology, namely, instruments for treating eye diseases and conditions; droppers for administering medication, sold empty; medical cutting devices; measuring devices for medical use, namely blood pressure measuring apparatus; telemetry devices for medical applications; tonometers; medical imaging apparatus; droppers for medical use, namely, eye droppers; sutures and suture materials and medical devices for closing wounds; pharmaceutical instruments, namely injection device for pharmaceuticals; cups for dispensing medicine; apparatus for administering medicines, namely, spoons; droplet dispensing devices for medical use, namely droppers and dropper bottles for administering medication, sold empty; ointment dispensing devices in the nature of syringes, sold empty, for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 25, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 11, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 22, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 27, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 3, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 3, 2023FIMPFINAL DISPOSITION PROCESSED—
Jan 18, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 18, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 18, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 9, 2022GPNXNOTIFICATION PROCESSED BY IB—
Aug 2, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 2, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 13, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 13, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 23, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 16, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 4, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 9, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2021ALIEASSIGNED TO LIE—
Nov 4, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 5, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 5, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Jun 5, 2021CNSLSUSPENSION LETTER WRITTEN—
May 11, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 10, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2021RFNTREFUSAL PROCESSED BY IB—
Feb 10, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 10, 2021RFRRREFUSAL PROCESSED BY MPU—
Feb 10, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2021DOCKASSIGNED TO EXAMINER—
Dec 8, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 3, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance